SoYoung Kwon - 06 Aug 2025 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Aug 2025, 16:29:09 UTC
Prior SEC filing
21 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ SoYoung Kwon

Key filing fact

SoYoung Kwon filed Form 4 for Aptevo Therapeutics Inc. (APVO) on 08 Aug 2025.

Key facts

  • This page summarizes SoYoung Kwon's Form 4 filing for Aptevo Therapeutics Inc. (APVO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 08 Aug 2025, 16:29.

Change

  • Previous filing in this sequence was filed on 21 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001864406 Primary reporting owner

Kwon SoYoung

Relationship
SVP, GC, BD & Corp Affairs
Address
2401 4TH AVENUE, SUITE 1050, SEATTLE
Signature
/s/ SoYoung Kwon
Signature date
08 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APVO transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+11,500
Change %
Price
$0.000000
Shares after
11,500
Date
06 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,500
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

Footnote F2

The RSUs vest in full on the first anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .